How Analysts Feel About ESSENTRA PLC ORDINARY SHARES UK (OTCMKTS:FLRAF) After Decrease in Sellers?

ESSENTRA PLC (OTCMKTS:FLRAF) Logo

The stock of ESSENTRA PLC ORDINARY SHARES UK (OTCMKTS:FLRAF) registered a decrease of 0.32% in short interest. FLRAF’s total short interest was 521,600 shares in December as published by FINRA. Its down 0.32% from 523,300 shares, reported previously.

It closed at $6.69 lastly. It is down 0.00% since December 8, 2017 and is . It has underperformed by 15.62% the S&P500.

Essentra plc manufactures and supplies specialist plastic, fiber, foam, and packaging products worldwide. The company has market cap of $. The firm operates through three strategic business units: Component Solutions, Health & Personal Care Packaging, and Filtration Products. It currently has negative earnings. The Component Solutions strategic business unit offers plastic injection molded, vinyl dip-molded, and metal items for equipment manufacturing, automotive, fabrication, electronics, and construction industries, as well as component solutions for protection and finishing purposes.

More notable recent ESSENTRA PLC (OTCMKTS:FLRAF) news were published by: Prnewswire.com which released: “Aleafia Health Inc. Joins the OTCQX Best Market in the United States – PR Newswire” on June 13, 2018, also Seekingalpha.com with their article: “Babcock International Group Plc 2018 Q4 – Results – Earnings Call Slides – Seeking Alpha” published on May 23, 2018, Seekingalpha.com published: “Roche Holding Ltd ADR 2016 Q3 – Results – Earnings Call Slides – Seeking Alpha” on October 20, 2016. More interesting news about ESSENTRA PLC (OTCMKTS:FLRAF) were released by: Seekingalpha.com and their article: “Chugai Pharmaceutical (CHGCF) Updates On Projects under Development (R&D Call) – Slideshow – Seeking Alpha” published on June 29, 2017 as well as Seekingalpha.com‘s news article titled: “Essentra PLC ADR 2018 Q2 – Results – Earnings Call Slides – Seeking Alpha” with publication date: August 06, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.